Pfizer/BioNTech seek approval of COVID vaccine for young children in Japan - Reuters
Justin Sullivan         

Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) are seeking approval of their COVID-19 vaccine from Japan's health ministry for use inÂ children aged six months to four years, Reuters reported.
In June,Â Pfizer-BioNTech three-dose regimen that spans nearly three months and a two-shot series from Moderna (MRNA) that takes four weeks, was given emergency use authorization and rolled out in the U.S. for the same population.